RJT
RPRX icon

Raymond James Trust’s Royalty Pharma RPRX Stock Holding History

Raymond James Trust’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$703K Buy
24,858
+12,936
+109% +$358K 0.02% 629
2024
Q2 		$314K Sell
11,922
-27
-0.2% -$748 0.01% 958
2024
Q1 		$363K Buy
+11,949
New +$352K 0.01% 877

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James Trust's RPRX Position: Q3 2024 in Review

Raymond James Trust increased its Royalty Pharma (RPRX) stake by 109% in Q3 2024, buying an estimated $358K and bringing the position to 24,858 shares worth $703K. The position accounts for 0.02% of the portfolio, ranked #629.

Raymond James Trust first reported a position in RPRX in Q1 2024 and has held it in 3 quarters since. 395 funds tracked by Wall St. Rank hold RPRX as of Q3 2024.

  • Raymond James Trust held 24,858 shares of Royalty Pharma worth $703K as of Q3 2024.
  • Raymond James Trust bought 12,936 Royalty Pharma shares in Q3 2024, an estimated $358K.
  • Royalty Pharma made up 0.02% of Raymond James Trust's portfolio in Q3 2024, its #629 holding.
  • Raymond James Trust first reported a position in Royalty Pharma in Q1 2024 and has held it in 3 quarters since.
  • 395 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.